​​Grants For The Year of 2022


​Grant Title

​Granting Agency

​Grant Code Active

​Grant Amount

​Grant period​

​Dr. Za​​hra Ha​san

Role of pegylated Interferon in SARS-CoV2 viral clearance and immunologic outcomes in COVID-19 patient using blood transcription profiling​​ferozsons
PKR 3,000,000​May 2022-May 2023​

Dr. Aysha Ha​bi​​b

Vitamin D deficiency (VDD) is a significant public health problem.​Pharm Evo
53403​PKR 2638094​Dec 2022 - Nov 2023​

Dr. R​​umina H​asan

Technical Assistance for Finalization of Prevalence Survey Protocols of National TB Prevalence Survey in Pakistan​Royal Tropical Institute​​53335
USD 3916​10 March 2022-14 May 2022​

​Dr. Rumina​​ Hasa​​n

Evaluation missions for programmatic management of drug resistance tb (pmdt).​WHO​53365​USD 4000​05-30 June 2022​

​Dr. Rumina ​Ha​san

Evaluation of DPP typhoid assay (Chembio Diagnostic System, Inc) for the diagnosis of typhoid from well characterized serum sample.  ​Typhoid​​51879
USD 9510​​Aug 22- Oct 22

​Dr. Rumina Has​​an​

Evaluation study of commercially available Rapid Diagnostic Tests (RDTs) detecting antigen and antibodies against Dengue virus​The Foundation for lnnovative New Diagnostics​53326​USD 101,196​​March 2022-Feb 2023

Dr. Hafsa Ma​jid​​

Curriculum Development using a Virtual community of practice (CoP) for postgraduate trianees ​SoTL​72108​
USD 3129​Jan22 - Jan 23​

Dr. Adan Zubair​​​​​

Azole resistance and CYP51 gene mutations in Aspergillus Flavus​RRG​​Dept funds
PKR 3,000,00​Jan 2022- Dec 2022​

​Dr. Syeda Maria Ahmad Zaidi​

​Role of H3F3A (43G34W) Antibody in the Diagnosis of Giant Cell Tumour of Bone in the Paediatric Age Group
​PKR 356,500
Dec 2022 - Nov 2023​​

Mentor Dr. Seema Irfan- Dr. Arsalan Ashraf
Resident / Hira Khan
Student  ​

Evaluation of sensitivity and specificity of rapid molecular method to assess MRSA Colonization of patients at Aga Khan University Hospital​​​



PKR 222,000​

12 months​

​Mentor Dr. Kausar Jabeen- Dr. Adan Zubair
Resident / Amna Irfan Ansari Student 

​Azole resistance and CYP51 gene mutations in Aspergillus flavus: comparing clinical and environmental isolates​​



PKR 300,000​

12 months​​

Dr. M. Asim Beg

Finding treatments for COVID-19: A phase 2 multi-centre adaptive platform trial to assess antiviral pharmacodynamics in early symptomatic COVID-19



GBP 906077​​

Sep 2022- Aug 2024

Drs. Shahid Pervez, Quratulain Chundriger, Moghira Siddiqi, Tazeen Ali and Namrah Anwar

Contextual predictors and survival rates of Head and Neck Cancer: A Case series study



Euro 5000

April – November 2022.

Dr. Zahra Hasan

SARS-CoV-2 genetic variation and its impact on immunity in COVID-19 Association of viral lineages with host Immuno-Biology

HEC fund 


PKR 114,918,693

March 2022-Dec 2024.​​

​Dr. Sayed Ali Raza Shah Bukhari

​Next-gen sequencing of host mitochondrial DNA to elucidate host- response in COVID19 crisis



​PKR 10500000

​24 months

​Drs. M. Asim Beg

​Effectiveness Of novel approaches to Radical cure with Tafenoquine and primaquine (EFFORT)- A randomized controlled trial in P. vivax patients

​Menzies School of Health Research


USD 404771

​Jan 2​​​022-Dec 2023​

​Dr. Rumina Hasan

​Surveillance of antimicrobial-resistant Gram negative bacteria and fungi in a Pakistan health care system

​Centers for Disease Control & Prevention


​USD 442,846

​Jan 2022- Dec 2022​